- Home
- MHUA vs ATHA Comparison
MHUA vs ATHA Comparison
Compare MHUA & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- ATHA
- Stock Information
- Founded
- MHUA 1990
- ATHA 2011
- Country
- MHUA China
- ATHA United States
- Employees
- MHUA N/A
- ATHA N/A
- Industry
- MHUA Medical Specialities
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- MHUA Health Care
- ATHA Health Care
- Exchange
- MHUA Nasdaq
- ATHA Nasdaq
- Market Cap
- MHUA 19.6M
- ATHA 15.7M
- IPO Year
- MHUA 2022
- ATHA 2020
- Fundamental
- Price
- MHUA $0.37
- ATHA $0.37
- Analyst Decision
- MHUA
- ATHA Buy
- Analyst Count
- MHUA 0
- ATHA 4
- Target Price
- MHUA N/A
- ATHA $11.25
- AVG Volume (30 Days)
- MHUA 168.0K
- ATHA 293.7K
- Earning Date
- MHUA 09-19-2025
- ATHA 08-12-2025
- Dividend Yield
- MHUA N/A
- ATHA N/A
- EPS Growth
- MHUA N/A
- ATHA N/A
- EPS
- MHUA 0.40
- ATHA N/A
- Revenue
- MHUA $96,909,642.00
- ATHA N/A
- Revenue This Year
- MHUA N/A
- ATHA N/A
- Revenue Next Year
- MHUA N/A
- ATHA N/A
- P/E Ratio
- MHUA $0.93
- ATHA N/A
- Revenue Growth
- MHUA N/A
- ATHA N/A
- 52 Week Low
- MHUA $0.25
- ATHA $0.22
- 52 Week High
- MHUA $1.26
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- MHUA 39.91
- ATHA 47.14
- Support Level
- MHUA $0.38
- ATHA $0.34
- Resistance Level
- MHUA $0.41
- ATHA $0.51
- Average True Range (ATR)
- MHUA 0.03
- ATHA 0.05
- MACD
- MHUA -0.01
- ATHA -0.01
- Stochastic Oscillator
- MHUA 9.10
- ATHA 25.41
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.